Metolazone
- Product NDC
- 58657-740
- 11-digit product format
- 586570740
- Labeler code
- 58657
- Product ID
- 58657-740_4a96f40b-ed89-0892-e063-6394a90a947d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Metolazone
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Method Pharmaceuticals, LLC
- Application
- ANDA213827
- Marketing category
- ANDA
- Marketing start
- 2024-06-15
- Substance
- METOLAZONE
- Active strength
- 2.5 mg/1
- Pharmacologic classes
- Increased Diuresis [PE], Thiazide-like Diuretic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Metolazone
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| METOLAZONE | 2.5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | TZ7V40X7VX |
| Rxcui | 197978, 197979, 311671 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 58657-740-01 | Metolazone | 100 in 1 BOTTLE | TABLET | 100 | | 5 |
| 58657-740-10 | Metolazone | 1000 in 1 BOTTLE | TABLET | 1000 | | 5 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 58657-740 | METOLAZONE TABLET [METHOD PHARMACEUTICALS, LLC] | 1 | Current NDC, 2 package rows | 20240617_1a8c38aa-362e-6bcc-e063-6294a90a1e05.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 58657-740-01 | 58657074001 | 100 TABLET in 1 BOTTLE (58657-740-01) | 100 tablet | 2024-06-15 | No | No | Current |
| 58657-740-10 | 58657074010 | 1000 TABLET in 1 BOTTLE (58657-740-10) | 1000 tablet | 2024-06-15 | No | No | Current |